NHL: Clinical Trials

4 trials for NHL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 13Completed 3

Follow NHL: new trials by email Literature Review of NHL trials Research Report on NHL

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Vysis LSI MYC Break Apart Rearrangement Probe Kit, Venetoclax, VIP152 - Lymphoma, Non-Hodgkin Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)82023-04-052026-02-23
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
veltuzumab - NHL, Lymphoma, Non-Hodgkin
Phase 1 / Phase 2CompletedGilead Sciences322008-01-012021-08-16
Safety Study of NHL With 90Y-hLL2 IgG
90Y-hLL2 - NHL, B-cell NHL
Phase 1 / Phase 2CompletedGilead Sciences592002-08-012021-08-16
Allogeneic Transplantation From Related Haploidentical Donors
non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin, Cyclosporine - Blood Cancer, Leukemia
Phase 2CompletedStanford University162000-08-012019-12-04

Narrower conditions

Lymphoma, Non-Hodgkin (3)  ·  Hematologic Neoplasms (2)  ·  Leukemia (2)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Graft vs Host Disease (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Prolymphocytic (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Neoplasms (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms by Histologic Type (4)  ·  Hematologic Diseases (3)  ·  Lymphoma (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Leukemia, B-Cell (1)

Interventions

Acetaminophen (1)  ·  Antilymphocyte Serum (1)  ·  Biopsy (1)  ·  Cyclosporine (1)  ·  Diphenhydramine (1)  ·  Echocardiography (1)  ·  Electrocardiography (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Hydrocortisone (1)  ·  Magnetic Resonance Imaging (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Acetate (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)

Sponsors

Gilead Sciences (2)  ·  National Cancer Institute (NCI) (1)  ·  Stanford University (1)

Countries

United States (3)  ·  France (1)  ·  Germany (1)

Top investigators

Christopher J Melani, M.D. (1)  ·  Robert Lowsky (1)  ·  William A Wegener, MD, PhD (1)  ·  William Wegener, MD, PhD (1)

Results publications

PMID 21173095, PMID 26389849, PMID 37882668